246 related articles for article (PubMed ID: 32445720)
1. Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates.
Wang SJ; Wade E; Towle J; Hachey T; Rioux J; Samuels O; Bonner C; Kirkpatrick C; O'Loughlin S; Foster K
Am J Med; 2020 Nov; 133(11):1343-1349. PubMed ID: 32445720
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections.
Marks LR; Munigala S; Warren DK; Liss DB; Liang SY; Schwarz ES; Durkin MJ
J Infect Dis; 2020 Sep; 222(Suppl 5):S513-S520. PubMed ID: 32877547
[TBL] [Abstract][Full Text] [Related]
3. Association of Hospital Discharge Against Medical Advice With Readmission and In-Hospital Mortality.
Tan SY; Feng JY; Joyce C; Fisher J; Mostaghimi A
JAMA Netw Open; 2020 Jun; 3(6):e206009. PubMed ID: 32525546
[TBL] [Abstract][Full Text] [Related]
4. Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: A matched cohort study.
Robertson NM; Mangino AA; South AM; Fanucchi LC
J Subst Use Addict Treat; 2024 May; 160():209298. PubMed ID: 38262559
[TBL] [Abstract][Full Text] [Related]
5. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis.
Suzuki J; Robinson D; Mosquera M; Solomon DA; Montgomery MW; Price CD; Johnson JA; Martin B; Liebschutz JW; Schnipper JL; Weiss RD
Am J Addict; 2020 Mar; 29(2):155-159. PubMed ID: 31930608
[TBL] [Abstract][Full Text] [Related]
6. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis.
Suzuki J
Am J Addict; 2016 Apr; 25(3):191-4. PubMed ID: 26991660
[TBL] [Abstract][Full Text] [Related]
7. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
Cottrill CB; Matson SC
Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
[No Abstract] [Full Text] [Related]
8. Evaluation of Clinical Outcomes of Intravenous Drug Use-Related Infective Endocarditis in Buprenorphine-Treated Patients.
O'Kane C; Piechowski K; Hoff A; Fang W; Mallow Z; Marshalak P; Burwell S
J Pharm Pharm Sci; 2022; 25():266-273. PubMed ID: 36054929
[TBL] [Abstract][Full Text] [Related]
9. The Shelby Clinic Medication-Assisted Treatment for Opioid Addiction.
Penn CL
J Ark Med Soc; 2016 Aug; 113(2):30-32. PubMed ID: 30047628
[No Abstract] [Full Text] [Related]
10. Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study.
Abrahamsson T; Widinghoff C; Lilliebladh A; Gedeon C; Nilvall K; Hakansson A
Subst Abus; 2016; 37(1):104-9. PubMed ID: 26176490
[TBL] [Abstract][Full Text] [Related]
11. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results.
Klein AA; Seppala MD
J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985
[TBL] [Abstract][Full Text] [Related]
12. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
13. Integration of buprenorphine for substance-abuse treatment by HIV care providers.
Friedland G; Vlahov D
J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S1-2. PubMed ID: 21317588
[No Abstract] [Full Text] [Related]
14. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.
Cushman PA; Liebschutz JM; Anderson BJ; Moreau MR; Stein MD
J Subst Abuse Treat; 2016 Sep; 68():68-73. PubMed ID: 27431049
[TBL] [Abstract][Full Text] [Related]
16. Use and misuse of opioid replacement therapies: a Queensland study.
Smirnov A; Kemp R
Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
[TBL] [Abstract][Full Text] [Related]
17. State variation in opioid treatment policies and opioid-related hospital readmissions.
Blanchard J; Weiss AJ; Barrett ML; McDermott KW; Heslin KC
BMC Health Serv Res; 2018 Dec; 18(1):971. PubMed ID: 30558595
[TBL] [Abstract][Full Text] [Related]
18. Treatment Experiences for Patients Receiving Buprenorphine/Naloxone for Opioid Use Disorder: A Qualitative Study of Patients' Perceptions and Attitudes.
Young GJ; Hasan MM; Young LD; Noor-E-Alam M
Subst Use Misuse; 2023; 58(4):512-519. PubMed ID: 36762464
[No Abstract] [Full Text] [Related]
19. Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: "Ultrarapid Micro-Dosing" Proof of Concept.
Azar P; Mathew N; Mahal D; Wong JSH; Westenberg JN; Schütz CG; Greenwald MK
J Psychoactive Drugs; 2023; 55(1):94-101. PubMed ID: 35152847
[TBL] [Abstract][Full Text] [Related]
20. The problem of pain: Additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder.
Montalvo C; Genovese N; Renner J
Subst Abus; 2019; 40(2):136-139. PubMed ID: 30835647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
